Drugs
-
Olmesartan (marketed as Benicar) Information
Benicar (olmesartan) is in the class of drugs called angiotensin II receptor blockers (ARBs). It is approved for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
-
Related Information
FDA Drug Safety Communication: Safety Review Update of Benicar (olmesartan) and cardiovascular events
4/14/2011FDA Drug Safety Communication: Ongoing safety review of the angiotensin receptor blockers and cancer
7/15/2010FDA Drug Safety Communication: Ongoing safety review of Benicar(olmesartan) and cardiovascular events
6/11/2010FDA Drug Safety Podcast for Healthcare Professionals: Ongoing safety review of Benicar and cardiovascular events
6/2011Benicar (olmesartan): Ongoing Safety Review
MedWatch (6/11/2010) Updated (4/14/2011)Angiotensin Receptor Blockers (ARBs) Information
-
-
Labeling and Regulatory History from Drugs@FDA
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-
